Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03396211
Title Study to Evaluate Apatinib Plus Nivolumab in Patients With Unresectable or Metastatic Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors LSK BioPartners Inc.
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.